On August 31, 2022, the US Food and Drug Administration amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 vaccines. This amendment authorized bivalent formulations of the vaccines for use as a single booster dose. This blog aims to detail how the new COVID-19 booster shots differ from previous formulas, the effectiveness and… Continue reading New COVID-19 Booster Shots
In the second part of VIGILINT’s two-part series COVID-19 1 Year Later, VIGILINT Ops Analyst and blogger Colin Schilly dives into the two critical hallmarks of the pandemic. Testing and vaccines. The development and rollout of several effective vaccines in under a year offer great hope for the pandemic’s end. Sadly, that day may still… Continue reading COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines
COVID-19 VACCINES FAQ JAN13
The World Health Organization (WHO) became aware of the disease known as COVID-19 on December 31, 2019. Since then, there have been 86 million confirmed cases, over 1.8 million deaths, and 355,000 deaths in the U.S. alone. After months of effort and billions of dollars spent, distribution of the first COVID-19 vaccines is underway. A… Continue reading COVID-19 Vaccines: What are the Side Effects?